Modernizing Aeromedical Standards for Crohn’s Disease: A Risk-Stratified, Evidence-Informed Proposal for Waiver Reform

Clicks: 27
ID: 321379
2026
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Emerging

Ranked #42 of 76 articles by views in Military Medicine

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Naval aviation physical standards are designed to minimize the risk of sudden or subtle medical incapacitation that could degrade flight performance, compromise safety, or jeopardize mission completion. Within the current U.S. Navy Aeromedical Reference and Waiver Guide (ARWG), Crohn's disease (CD) remains categorically designated as "waivers not recommended" across all aviation classes, in contrast to ulcerative colitis, which may be considered for waiver in select designated personnel. This distinction reflects historical concerns regarding unpredictable disease activity and the risk of gastrointestinal complications requiring urgent intervention. However, advances in surgical techniques, pharmacologic therapies, nutritional strategies, and monitoring capabilities have substantially altered the natural history of CD for select patients in sustained remission. Contemporary evidence demonstrates that appropriately selected individuals may achieve durable disease control with stable medication regimens and objective evidence of mucosal healing, supporting a more individualized assessment of aeromedical risk. In an era of constrained recruitment and prolonged training pipelines, aeromedical policy must balance force preservation with uncompromised flight safety. Accordingly, revision of ARWG Section 7.2 to permit structured, case-by-case waiver consideration for designated aviators with CD who demonstrate sustained clinical remission, absence of aeromedically significant complications, and stability on steroid-free therapy is recommended. Temporary grounding would remain appropriate following diagnosis, medication changes, or disease flare, with return-to-flight determined through interval reassessment. Modernizing aeromedical policy to reflect contemporary risk stratification rather than categorical exclusion would align waiver decision-making with current gastroenterology practice and established aeromedical risk-management principles. Such an approach supports retention of qualified aviators while maintaining the operational safety standards essential to Naval Aviation readiness.
Reference Key
openalex_W7169619670 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Jake Cresta, J. Kwan, Stephanie Tamayo, Benjamin Fiore
Journal Military Medicine
Year 2026
DOI
10.1093/milmed/usag328
URL
https://doi.org/10.1093/milmed/usag328
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.